Vaccines, Blood & Biologics
-
2005 Safety and Availability Communications
This webpage was developed to provide the public with important information about the safety and availability of biological products.
-
Important Safety Alert: BacT/ALERT BacT/VIEW Users [ARCHIVED]NovoSeven Coagulation Factor VIIa (Recombinant) - Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine --- United States, June--July 2005
FDA and CDC Issue Alert on Menactra Meningococcal Vaccine and Guillain Barre Syndrome [ARCHIVED]DIC following Rho(D) Immune Globulin Intravenous Administration [ARCHIVED]Disseminated Intravascular Coagulation Associated with Acute Hemoglobinemia or Hemoglobinuria following Rho(D) Immune Globulin Intravenous Administration for Immune Thrombocytopenic Purpura (PDF - 68KB)Safety of Albumin Administration in Critically Ill Patients [ARCHIVED]Dear Doctor Letter - Albumin Use in Seriously Ill Patients [ARCHIVED]- Unapproved Home - Use Diagnostic Kits Marketed by Globus Media
Recall of Rapid HIV Test Kits-Globus Media, Inc [ARCHIVED]FDA Warns Consumers Not to Use Home-Use Diagnostic Kits Marketed by Globus Media - Talkpaper [ARCHIVED]Important Information Relating to Recall of Fetal Cell Screening Kit (FETALSCREEN) - Ortho-Clinical Diagnostics [ARCHIVED]Recall of Fetal Cell Screening Kit (FETALSCREEN) - Ortho-Clinical Diagnostics [ARCHIVED]
-
-
-
